Rovelizumab (ITGAL/CD11a/ITGB2/CD18) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer:
PRS-10-319
| Artikelname: |
Rovelizumab (ITGAL/CD11a/ITGB2/CD18) - Research Grade Biosimilar, Unconjugated, Monoclonal |
| Artikelnummer: |
PRS-10-319 |
| Hersteller Artikelnummer: |
10-319 |
| Alternativnummer: |
PRS-10-319-0.1 |
| Hersteller: |
ProSci |
| Kategorie: |
Antikörper |
| Immunogen: |
Humanized / ITGAL/CD11a/ITGB2/CD18 [Homo sapiens] |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
Hu23F2G |
| Klonalität: |
Monoclonal |
| Konzentration: |
batch dependent |
| Puffer: |
PBS buffer pH7.5 |
| Quelle: |
CHO cells |
| Application Verdünnung: |
Optimal dilutions for each application to be determined by the researcher. |
